The death rate is about 3% overall, which is the same as

New Post Public Reply Private Reply Replies (0) Message Board
blafarm craigakess #19831
499
Quote:
The death rate is about 3% overall, which is the same as the flu.


You make some very reasonable arguments, and I agree it's smart to try to keep things in perceptive. However, your assertion regarding the fatality rate being equal to the flu is currently impossible to empirically substantiate.

I'm not sure where you are getting your information from, but here are some excerpts from recent stories sourced from legitimate news outlets that may deserve consideration. At the end of the day, we probably won't know the actual fatality rate, and how it compares to the flu, until we get to the end of the first phase of the pandemic (assuming it becomes a full-fledged pandemic).

New York Times:
Link= https://www.nytimes.com/2020/02/29/health/cor...s-flu.html

Quote:
Which virus is deadlier?

The coronavirus seems to be more deadly than the flu — so far.

On average, seasonal flu strains kill about 0.1 percent of people who become infected. The 1918 flu had an unusually high fatality rate, around 2 percent. Because it was so contagious, that flu killed tens of millions of people.

Early estimates of the coronavirus death rate from Wuhan, China, the epicenter of the outbreak, have been around 2 percent. But a new report on 1,099 cases from many parts of China, published on Friday in The New England Journal of Medicine, finds a lower rate: 1.4 percent.

The coronavirus death rate may be even lower, if — as most experts suspect — there are many mild or symptom-free cases that have not been detected.

The true death rate could turn out to be similar to that of a severe seasonal flu, below 1 percent, according to an editorial published in the journal by Dr. Anthony S. Fauci and Dr. H. Clifford Lane, of the National Institute of Allergy and Infectious Diseases, and Dr. Robert R. Redfield, director of the Centers for Disease Control and Prevention.

But even a disease with a relatively low death rate can take a huge toll if enormous numbers of people catch it. As of Sunday, there were about 87,000 coronavirus cases and 3,000 deaths. This week, for the first time, the number of new cases outside China exceeded the number within the country.


U.S. News & World Report:
Link= https://www.usnews.com/news/health-news/artic...y-be-lower

Quote:
The latest tally of almost 1,100 cases of COVID-19 infection from 30 Chinese provinces shows a fatality rate of 1.4% during the early phase of the outbreak.

That's much higher than the rate seen with the seasonal flu, where only about 0.1% of cases end in death. But it's far below the mortality rate of recent coronavirus outbreaks like SARS (9 to 10%) or MERS (36%), noted Dr. Anthony Fauci, director of the U.S. National Institute of Allergy and Infectious Diseases (NIAID).
Furthermore, the 1.4% figure cited in the new Chinese report, published Feb. 28 in the New England Journal of Medicine, is probably higher than the "real" death rate, Fauci added.

That's because many coronavirus cases are so mild they're not even being reported, Fauci explained in an editorial he co-wrote in the same issue of the NEJM. Co-authors include Dr. Robert Redfield, who directs the U.S. Centers for Disease Control and Prevention, and Dr. Clifford Lane, deputy director of the NIAID.
"If one assumes that the number of asymptomatic or minimally symptomatic cases is several times as high as the number of reported cases, the case fatality rate may be considerably less than 1%," Fauci and his colleagues explained.

"This suggests that the overall clinical consequences of COVID-19 may ultimately be more akin to those of a severe seasonal influenza pandemic [which has a case fatality rate of approximately 0.1%] or a pandemic influenza [similar to those in 1957 and 1968]," the experts wrote.


MarketWatch:
Link= https://www.marketwatch.com/story/coronavirus...2020-02-26

Quote:
As the coronavirus spreads, scientists are learning more about the disease’s fatality rate.

The medical journal JAMA released a paper this week analyzing data from the Chinese Center for Disease Control and Prevention on 72,314 coronavirus cases in mainland China, the figure as of Feb. 11, the largest such sample in a study of this kind.

The sample’s overall case-fatality rate was 2.3%, higher than World Health Organization official 0.7% rate. No deaths occurred in those aged 9 years and younger, but cases in those aged 70 to 79 years had an 8% fatality rate and those aged 80 years and older had a fatality rate of 14.8%.

No deaths were reported among mild and severe cases. The fatality rate was 49% among critical cases, and elevated among those with preexisting conditions: 10.5% for people with cardiovascular disease, 7.3% for diabetes, 6.3% for chronic respiratory disease, 6% for hypertension, and 5.6% for cancer.

The fatality rate was 49% among critical cases and worsened among those with preexisting conditions.
The latest China-based study, which was not peer-reviewed by U.S. scientists, found that men had a fatality rate of 2.8% versus 1.7% for women. Some doctors have said that women may have a stronger immune system as a genetic advantage to help babies during pregnancy.

The Chinese study is likely not representative of what might happen if the global spread of the virus worsens, particularly as regards gender. In China, nearly half of men smoke cigarettes versus 2% of women, which could be one reason for the gender disparity.

Coronavirus has an incubation period of up to two weeks, helping the virus to spread. A previous study published in JAMA suggests some patients may be more contagious than others. One patient spread the virus to at least 10 health-care workers and four patients at a hospital in Wuhan.

“In this single-center case series of 138 hospitalized patients with confirmed novel coronavirus–infected pneumonia in Wuhan, China, presumed hospital-related transmission of 2019-nCoV was suspected in 41% of patients, 26% of patients received ICU care, and [the] mortality was 4.3%.”


LiveScience:
Link= https://www.livescience.com/new-coronavirus-c...h-flu.html

Quote:
Death rate

So far this flu season, about 0.05% of people who caught the flu have died from the virus in the U.S., according to CDC data.

The death rate for COVID-19 appears to be higher than that of the flu.

In the study published Feb. 18 in the China CDC Weekly, researchers found a death rate from COVID-19 to be around 2.3% in mainland China. That's much higher than the death rate linked to flu, which is typically around 0.1% in the U.S., according to The New York Times.

Even so, the death rate for COVID-19 varied by location and an individual’s age, among other factors. For instance, in Hubei Province, the epicenter of the outbreak, the death rate reached 2.9%; in other provinces of China, that rate was just 0.4%. In addition, older adults have been hit the hardest. The death rate soars to 14.8% in those 80 and older; among those ages 70 to 79, the COVID-19 death rate in China seems to be about 8%; it’s 3.6% for those ages 60 to 69; 1.3% for 50 to 59; 0.4% for the age group 40 to 49; and just 0.2% for people ages 10 to 39. Nobody 9 and under has died of this coronavirus to date.


The Guardian:
Link= https://www.theguardian.com/world/2020/mar/01...irus-myths

Quote:
Claim: ‘It is no more dangerous than winter flu’

Many individuals who get coronavirus will experience nothing worse than seasonal flu symptoms, but the overall profile of the disease, including its mortality rate, looks more serious. At the start of an outbreak the apparent mortality rate can be an overestimate if a lot of mild cases are being missed. But this week, a WHO expert suggested that this has not been the case with Covid-19. Bruce Aylward, who led an international mission to China to learn about the virus and the country’s response, said the evidence did not suggest that we were only seeing the tip of the iceberg. If borne out by further testing, this could mean that current estimates of a roughly 1% fatality rate are accurate. This would make Covid-19 about 10 times more deadly than seasonal flu, which is estimated to kill between 290,000 and 650,000 people a year globally.


BBC:
Link= https://www.bbc.com/news/health-51674743

_111074816_death_ratio-nc.png

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Viatris Declares Quarterly Dividend Amid Acquisition Buzz

Updated Category News Views 79

A Dividend Declaration with a Side of Mergers Viatris, the healthcare giant operating on a global scale, has been making some noise recently. On the surface, it's another quarterly dividend—$0.12 per share, set to hit the pockets of shareholders on December 16. But there's a lot more cooking under the hood of this announcement that ticks just about every box for a...

Continue Reading
Verismo's SynKIR™-310 Shows Promise in Phase 1 Trials

Updated Category News Views 61

KIR-CAR: A Fresh Take on Cancer Treatment So, Verismo Therapeutics is at it again with their KIR-CAR platform. They're set to present interim data at this year's ASH Annual Meeting. To all those following B-cell non-Hodgkin Lymphoma (B-NHL) treatments, pay attention. SynKIR™-310, a CD19-targeted therapy, is showing some real promise. The science behind this is like...

Continue Reading
SAFE's New Website: Engineering Excellence and Faith

Updated Category News Views 94

A Bold Digital Step for SAFE Structure Designs Now here's a move worth watching. SAFE Structure Designs, that U.S.-rooted defense contractor with its fingers in a multitude of engineering pies, just rolled out a fresh new face on the web. This isn't merely an online facelift; it's a declaration of ambition and capabilities. They're showcasing eight specialized divisions...

Continue Reading
Aeon Lands $13.8M Contract for Zeus Missile System

Updated Category News Views 165

Aeon's Big Win: SOCOM Contract for Zeus Well look at that! Aeon Industrial Inc. just snagged a pretty penny with a $13.8 million contract from the U.S. Special Operations Command (SOCOM). It's not every day a company gets to modernize the arsenal for the big leagues. This year-long deal wants Aeon at their sharpest, enhancing and testing the Zeus Missile System, known for...

Continue Reading
IM Digital Garners 2026 Klaviyo Partner Accolade

Updated Category News Views 122

Award Shows IM Digital's CRM Mastery It's not every day that a consultancy makes waves in the tech ocean, but IM Digital just scored a big one by nabbing the 2026 Klaviyo Global Partner of the Year award. When you see those shiny accolades, it's a testament to much more than just fancy buzzwords—it's about real grit and customer victories. Why It Matters in the CRM...

Continue Reading
Fluence Energy Lawsuit: Investors Face Key Deadline

Updated Category News Views 50

Fluence Energy Under Fire Fluence Energy, Inc., ain't having the best of times, folks. If you've been keeping an eye on the stock ticker NASDAQ:FLNC, you probably felt the shiver when the news of a securities fraud class action lawsuit hit the wire. This ain't about some minor slip-up. These allegations are rocking the boat hard. What's at Stake for Investors? Here's the...

Continue Reading
Navigating Builder-Ready Land: Avoid Costly Pitfalls

Updated Category News Views 18

Understanding the 'Builder-Ready' Label The term 'builder-ready' isn't as straightforward as it seems, especially when you're eye-balling land listings in rural areas. Cindy Garvey, a rural land expert, breaks down the frequent pitfalls buyers encounter when this label gets tossed around without much scrutiny. Utility Access Misconceptions Think utility access is a given?...

Continue Reading
Crocs™ Gains C2C Circularity Gold for Classic Clogs

Updated Category News Views 125

Turning Plastic into Gold Well, folks, Crocs isn't just about comfort anymore. They're wrapping their iconic Classic Clog in a shiny new accolade: Cradle to Cradle Certified® Circularity Gold Version 5.0. Imagine that—an award for making something meant to last, designed to be repurposed. They're not just slapping new paint on the same old clogs either. This...

Continue Reading
Peabody's Q3 2026: Margins Climb Despite Net Loss

Updated Category News Views 26

Tough Quarters but Promising Margins Alright, Peabody's Q3 2026 isn't the most sunshine-filled report I've laid eyes on, but it's not all shadows either. Sure, they posted a net loss of $32.8 million, better than last year's $70.1 million drain. Admit it or not, that's improvement. And yet, the real gem here is those expanding margins gleaming despite the loss-heavy...

Continue Reading
NSING's Bluetooth Milestone: A Signal for Investors

Updated Category News Views 68

The Bluetooth Bonanza: NSING Technologies' Big Win Amidst the bustling lanes of the semiconductor sector, NSING Technologies just threw down a whopper of an announcement—over 250 million Bluetooth chips shipped, all well-knitted with Ceva's technology. This isn’t just another milestone; it's a clarion call for anyone keeping an eye on the evolving landscape of...

Continue Reading

Top 5 Most Recently Viewed Articles

TTM Technologies Celebrates Awards and Leadership in Electronics

Updated Category News Views 229

TTM Technologies Recognizes Excellence at IPC CEMAC Conference SANTA ANA, Calif. — TTM Technologies, Inc. (NASDAQ: TTMI), a recognized leader in manufacturing technology products, has recently announced a remarkable achievement. During the 2025 IPC China Electronics Manufacturing Annual Conference (CEMAC), two esteemed members of the TTM team received renowned awards...

Continue Reading
OneAmerica Financial Declares Enhanced Dividend Rate for 2026

Updated Category News Views 313

OneAmerica Financial Declares Enhanced Dividend Rate for 2026 A prominent name in insurance and financial services, OneAmerica Financial, has made a significant announcement regarding its dividend allocation for policyholders of American United Life Insurance Company. This year, the company declared a notable increase in the dividend interest rate, which has risen by 10...

Continue Reading
Projected Growth in Drug-Device Combination Products Market

Updated Category News Views 152

Insights into the Drug-Device Combination Products Market The global drug-device combination products market is experiencing significant growth. Recent projections suggest that it is set to reach an impressive USD 389.7 billion by 2033, with a robust compound annual growth rate (CAGR) of 9.3% from 2024 onwards. As the healthcare landscape evolves, these combination...

Continue Reading
IPSEN's Recent Share Buy-Back Highlights and Market Impact

Updated Category News Views 168

Understanding IPSEN's Share Buy-Back Program The recent share buy-back program by IPSEN represents a strategic move in financial management. By repurchasing shares from the market, IPSEN aims to enhance shareholder value and positively impact its stock performance. Transaction Summary from Late July to Early August This segment provides an overview of IPSEN's transactions...

Continue Reading
Intensity Therapeutics Unveils Executive Stock Options to Drive Growth

Updated Category News Views 60

Stock Options Granted to Key Executives Intensity Therapeutics, Inc., a prominent biotechnology firm focused on innovative biological products, has recently made headlines by granting stock options to its key executives. This strategic move is part of the company's broader employee incentive program designed to foster loyalty and motivation among its top tier. Details of...

Continue Reading